Biolato, Marco http://orcid.org/0000-0002-5172-8208
Bianco, Assunta http://orcid.org/0000-0002-7101-0949
Giustiniani, Maria Cristina http://orcid.org/0000-0003-1649-3738
Mirabella, Massimiliano http://orcid.org/0000-0002-7783-114X
Pompili, Maurizio http://orcid.org/0000-0001-6699-7980
Article History
Received: 11 February 2024
Accepted: 31 March 2024
First Online: 8 April 2024
Declarations
:
: AB has served on advisory boards and/or has received travel grants and/or speaker honoraria from Merck, Biogen, Almirall, Novartis, and Sanofi-Genzyme. MM: scientific advisory board membership of Bayer Schering, Biogen, Sanofi-Genzyme, Merck, Novartis, Teva; consulting and/or speaking fees, research support or travel grants from Almirall, Bayer Schering, Biogen, CSL Behring, Sanofi-Genzyme, Merck, Novartis, Teva, Roche, Ultragenix; principal investigator in clinical trials for Biogen, Merck, Novartis, Roche, Sanofi Genzyme, Teva, Ultragenix, and CSL Behring. The rest of the authors have nothing to declare.
: The patient has provided informed consent for publication of the case.